137 related articles for article (PubMed ID: 917012)
21. Different roles of IgG and complement receptors in phagocytosis by polymorphonuclear leukocytes.
Mantovani B
J Immunol; 1975 Jul; 115(1):15-7. PubMed ID: 1151058
[TBL] [Abstract][Full Text] [Related]
22. Distinct functions of surface receptors in the induction of neutrophil-mediated cytotoxicity.
Cordier G; Samarut C; Revillard JP
Ann Immunol (Paris); 1981; 132D(1):3-14. PubMed ID: 7347555
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of C3 and IgG proteolysis enhances phagocytosis of Porphyromonas gingivalis.
Cutler CW; Arnold RR; Schenkein HA
J Immunol; 1993 Dec; 151(12):7016-29. PubMed ID: 8258706
[TBL] [Abstract][Full Text] [Related]
24. Functional properties of the asialo-fifth component of human complement.
Schultz DR; Arnold PI
J Immunol; 1990 Jul; 145(2):655-61. PubMed ID: 2114446
[TBL] [Abstract][Full Text] [Related]
25. A new activity of complement component C3: cell-bound C3b potentiates lysis of erythrocytes by C5b,6 and terminal components.
Hammer CH; Abramovitz AS; Mayer MM
J Immunol; 1976 Sep; 117(3):830-4. PubMed ID: 956655
[TBL] [Abstract][Full Text] [Related]
26. The role of opsonins in vacuolar sealing and the ingestion of zymosan by human neutrophils.
Kemp AS; Turner MW
Immunology; 1986 Sep; 59(1):69-74. PubMed ID: 3759128
[TBL] [Abstract][Full Text] [Related]
27. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
[TBL] [Abstract][Full Text] [Related]
28. Human polymorphonuclear leucocyte receptors for staphylococcal opsonins.
Verhoef J; Peterson PK; Quie PG
Immunology; 1977 Aug; 33(2):231-9. PubMed ID: 608687
[TBL] [Abstract][Full Text] [Related]
29. Effect of phagocytosis and Fc receptor occupancy on complement-dependent neutrophil chemotaxis.
Kay NE; Bumol TF; Douglas SD
J Lab Clin Med; 1978 May; 91(5):850-6. PubMed ID: 641406
[TBL] [Abstract][Full Text] [Related]
30. Freeze-thaw activation of the complement attack phase: II. Comparison of convertase generated C--56 with C--56 generated by freezing and thawing.
Dessauer A; Rother U; Rother K
Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():83-8. PubMed ID: 6444196
[TBL] [Abstract][Full Text] [Related]
31. IgA-mediated inhibition of human leucocyte function by interference with Fc gamma and C3b receptors.
Saito K; Kato C; Katsuragi H; Komatsuzaki A
Immunology; 1991 Sep; 74(1):99-106. PubMed ID: 1834550
[TBL] [Abstract][Full Text] [Related]
32. Phagocytosis of Plasmodium falciparum-parasitized erythrocytes by human polymorphonuclear leukocytes.
Celada A; Cruchaud A; Perrin LH
J Parasitol; 1983 Feb; 69(1):49-53. PubMed ID: 6338199
[TBL] [Abstract][Full Text] [Related]
33. Cyanate as an inactivator of complement proteins.
Schultz DR; Arnold PI
J Immunol; 1975 Dec; 115(6):1558-65. PubMed ID: 1184967
[TBL] [Abstract][Full Text] [Related]
34. Complement inhibition with an anti-C5 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation.
Kroshus TJ; Rollins SA; Dalmasso AP; Elliott EA; Matis LA; Squinto SP; Bolman RM
Transplantation; 1995 Dec; 60(11):1194-202. PubMed ID: 8525509
[TBL] [Abstract][Full Text] [Related]
35. Complement levels and leucocyte phagocytosis in newborn babies.
Arinola OG; Obisesan KA; Afolabi K; Salimonu LS
Afr J Med Med Sci; 2003 Dec; 32(4):401-4. PubMed ID: 15259926
[TBL] [Abstract][Full Text] [Related]
36. Demonstration of C5 cleaving activity in bronchoalveolar fluids and cells: a mechanism of acute and chronic alveolitis.
Desai U; Dickey B; Varani J; Kreutzer DL
J Exp Pathol; 1984; 1(3):201-16. PubMed ID: 6400640
[TBL] [Abstract][Full Text] [Related]
37. Modulation of FcR function by complement: subcomponent C1q enhances the phagocytosis of IgG-opsonized targets by human monocytes and culture-derived macrophages.
Bobak DA; Gaither TA; Frank MM; Tenner AJ
J Immunol; 1987 Feb; 138(4):1150-6. PubMed ID: 3492544
[TBL] [Abstract][Full Text] [Related]
38. Identity of C3- and C5-receptors on lymphoid cells.
Landen B; Dierich MP
J Immunol; 1979 Mar; 122(3):1015-7. PubMed ID: 448068
[TBL] [Abstract][Full Text] [Related]
39. Role of TraT protein, an anticomplementary protein produced in Escherichia coli by R100 factor, in serum resistance.
Pramoonjago P; Kaneko M; Kinoshita T; Ohtsubo E; Takeda J; Hong KS; Inagi R; Inoue K
J Immunol; 1992 Feb; 148(3):827-36. PubMed ID: 1730875
[TBL] [Abstract][Full Text] [Related]
40. [Defects in opsonization activity of the serum of patients with chronic arthritis].
Böhm U; Merétey K; Seszták M; Hodinka L; Koó E; Zahumenszky Z
Z Rheumatol; 1988; 47(3):161-5. PubMed ID: 3213263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]